09:55 AM EST - Vasogen Inc. : reported third-quarter net loss of $1.2 million or $0.05 per share, compared to a net loss of $2.6 million or $0.12 per share last year. Research and development expenses for the quarter declined to $7,000 from $1.1 million a year ago. Net loss for the nine months ended August 31, 2009 was $4.5 million, or $0.20 per share, compared with a net loss of $15.3 million, or $0.68 per share for the same period in 2008. Vasogen Inc.
shares T.VAS are trading even at $0.28.
